Pages
- About Us
- Account Setup
- AmnioText vs Other Membrane Grafts
- AmnioText Wound Care
- AmnioText™
- Protected: Amniotic Membrane
- Applications
- BIAF
- BIAF Physician Time and Services Donation
- Clinical Site Enrollment
- Coded Products
- Connective Tissue Supplementation
- Contact
- Contact Us – Patient
- Contact Us – Providers
- CryoText™
- Distributor
- For Patients
- For Providers
- Frequently Asked Questions
- FROM THE CEO
- Home
- Join Our Research Community + Pursuit Of Patient Outcomes
- Let’s Work Together
- MedNgine
- News
- Non-Coded Products
- Podiatrist Wound Care
- Privacy Policy
- Product Compliance
- Products
- ProText™
- Regenative Labs Clinic Support
- Research Not Rebates
- Secretext™
- Showcase your practice, Joint press release and publication
- Sitemap
- Protected: Wharton’s Jelly
- Wharton’s jelly vs HA, Steroid, PRP, BMAC
- What are Wharton’s Jelly Allografts?
- What is Section 361
Applications
- Aesthetics
- Ankle/Feet
- Data Program
- Hand/Wrist
- Hips
- Knee
- Men’s Health
- Men’s Health: COMING SOON
- Shoulder
- Spine
- TMJ
- Women’s Health
- Women’s Health: COMING SOON
- Wound Care
Specialties
Posts
- Regenative Labs Returned from a Successful PAINWeek 2024
- Join Regenative Labs at PAINWeek 2024, September 3-6, at The Cosmopolitan, Las Vegas
- Join Regenative Labs at the Spring Symposium on Advanced Wound Care (SAWC)
- Retrospective Study: Wharton’s Jelly Tissue Allograft for Connective Tissue Defects Surrounding Nerves in the Tarsal Tunnel
- Join Regenative Labs at A4M’s 32nd Annual Congress
- Regenative Labs’ Latest Published Study Demonstrates The Safety And Efficacy Of Wharton’s Jelly Connective Tissue Allograft For Rotator Cuff Tears
- Regenative Labs, with Advanced Medicine of The Ozarks, Publishes Case Series Demonstrating Utilization of Wharton’s Jelly Allografts in Supplementing Connective Tissue Defects Associated with Tarsal Tunnel Syndrome
- Dr. Lavor Helps Patient Avoid Amputation with Wharton’s Jelly Allograft
- Exploring and Understanding the Role of Wharton’s Jelly Tissue Allografts in TMJ Defects
- Research Findings Present Solutions For Knee Degradation
- Career Trajectory of NBA Players Who Suffered from Achilles Tendon Injuries
- Join Regenative Labs at the Longevity Fest 2023
- Join Regenative Labs at the Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference
- Retrospective Study: Umbilical Cord Tissue in TMJ Defects
- Regenative Labs & Dr. Robert Parker: Wharton’s Jelly in Achilles Care
- Dr. Carl Speer Joins Regenative Labs for Brothers in Arms Cause
- Regenative Labs: Case Study on Wharton’s Jelly Allografts in TMJ Defects
- Regenative Labs & Brothers in Arms: $5M Partnership for Veteran Care
- A Letter From Our CEO for Regenerative Medicine
- Regenative Labs: Wharton’s Jelly Study on TMJ Defects
- Regenative Labs & Dr. Michael Lavor: Charcot Foot Study
- Regenative Labs Presents Wharton’s Jelly Studies at Wound Care Symposium
- Regenative Labs: Breakthrough Wharton’s Jelly Paper for Si Joint Treatment
- The Durability and Efficacy of Cryopreserved Human Umbilical Cord Tissue Allograft for the Supplementation of Cartilage Defects Associated with the Sacroiliac Joint: A Case Series
- Regenative Labs Updates Wharton’s Jelly Knee Study
- Regenative Labs & Dr. Albert Lai: Wharton’s Jelly in Si Joint Care
- Novel Use: Umbilical Cord Tissue in Sacral Ulcers
- Regenative Labs: Wharton’s Jelly in Post-Surgical Breast Care
- Application of Umbilical Cord Tissue Allografts in Reduction Mammoplasty Wound: A Case Study
- Wharton’s Jelly Advancements: Post-Surgical Breast Reduction
- Regenative Labs Advances through Value-Based Outcomes
- Research, Not Rebates
- Application of Amniotic Membrane Allografts in Advanced Venous Leg Ulcer: A Case Study and Literature Review
- Evaluation of the Efficacy of Cryopreserved Human Umbilical Cord Tissue Allografts to Augment Functional and Pain Outcome Measures in Patients with Knee Osteoarthritis: An Observational Data Collection Study
- Regenative Labs’ Study Opens The Door For Advanced Treatment Of Degenerating Tissue In Knee Joints
- Regenative Labs announces groundbreaking Wharton’s Jelly research demonstrating HCT/P compliance after processing
- Three-Dimensional Electron Microscopy of Human Umbilical Cord Tissue Allograft Pre and Post Processing: A Literature Comparison
- Regenative Labs Releases New Study To Revolutionize Treatment For Patients With Diabetic Foot Ulcers
- Regenative Labs And AAPC Announce Collaboration To Further Healthcare Compliance
- Application of Dehydrated Amniotic Membrane Allografts in Advanced Diabetic Foot Ulceration: Case Report and Review of Literature
- Institutional Review Board Approves Regenative Labs’ Protocol For Key Data Collection
- Independent Research
- Bone Marrow Aspirate Concentrate for the Treatment of Knee Osteoarthritis: A Systematic Review
- A Letter from the CEO
- Regenative Labs: Medicare Approval for Wharton’s Jelly Reimbursement
Articles
- Regulatory Considerations for HCT/Ps: Minimal Manipulation – Regenative Labs
- Surgical Procedure Exception: Q&A under 21 CFR 1271.15(b) – Regenative Labs
- Deviation Reporting for HCT/Ps under PHS Act and 21 CFR 1271 – Regenative Labs
- Revised Eligibility Guidelines: Donors of Human-Derived Clotting Factors
- Adverse Reactions Reporting for HCT/Ps
- Donor Screening for Treponema Pallidum Infection
- Good Tissue Practice & Requirements for HCT/Ps Manufacturers
- HCT/Ps from Donors Tested for Communicable Diseases
- HCT/Ps Regulation: Small Entity Compliance Guide – Regenative Labs
- Donor Eligibility for HCT/Ps
- Compliance with 21 CFR Part 1271.150(c)(1) – Manufacturing Arrangements
- Labeling Claim for Communicable Disease Donor Screening with Cadaveric Blood in HCT/Ps – Regenative Labs
- Validation for Human Tissue Processing – Regenative Labs
- HCT/Ps Establishment Registration – Regenative Labs